老年慢性阻塞性肺疾病与骨质疏松症关系的研究(附36例分析) 被引量：3

导出

摘要目的:探讨老年慢性阻塞性肺疾病(COPD)与骨质疏松症关系。方法:采用双能X线骨密度测定仪测定72例对象腰椎L2～L4节段和右侧股骨的骨密度,记录各组对象骨质疏松的发生率。结果:随着COPD分级的加重,肺功能损害程度就越严重,骨质疏松的发生率也随之升高。不同分级的COPD患者骨质疏松发生率与对照组比较,差异有统计学意义(P<0.05)。结论:中、重度COPD患者骨质疏松症的发生率较高,COPD是骨质疏松发生的重要相关因素。

作者陈浩忠

机构地区广东省兴宁市人民医院

出处《吉林医学》 CAS 2011年第9期1706-1706,共1页 Jilin Medical Journal

关键词慢性阻塞肺疾病性骨质疏松相关性

分类号 R580 [医药卫生—内分泌] R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献3

1杨菊,张燕祺,马蕾,刘彬,莫艳萍.老年慢性阻塞性肺疾病与骨质疏松症的相关性研究[J].中国老年保健医学,2009,7(4):31-33. 被引量：13
2陈红,李为民.慢性阻塞性肺病和骨质疏松[J].国际内科学杂志,2008,35(11):653-656. 被引量：14
3李春陵,王茹,唐国惠.老年男性慢性阻塞性肺疾病与骨质疏松症的相关性研究[J].贵州医药,2008,32(8):736-737. 被引量：5

二级参考文献38

1高书元,马定千,杨成,燕春茂.高原地区汉藏之间骨质疏松调查[J].中国骨质疏松杂志,1996,2(2):76-77. 被引量：6
2李卫,苗懿德.老年男性慢性阻塞性肺疾病患者骨代谢的研究[J].中国骨质疏松杂志,2005,11(2):221-224. 被引量：14
3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量：1798
4Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med, 2005, 26(2) :142-153.
5Jorgensen NR, Schwarz P, Holme I, et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med, 2007, 101 ( 1 ) : 177-185.
6Dimai HP, Domej W, Leb G, et al. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res, 2001, 16( 11 ) :2132-2141.
7Vrieze A, de Greef MH, Wijkstra PJ, et al. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osleoporos Int, 2007, 18(9) :1197-1202.
8Kjensli A, Mowinckel P, Ryg MS, et al. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone, 2007, 40(2) :493-497.
9Bolton CE, lonescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004, 170(12) : 1286-1293.
10Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin in Pulm Med, 2004, 10(2) :98-103.

共引文献26

1李涛,于涛.吸烟性骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2010,16(5):381-386. 被引量：22
2周俊荣.沙美特罗替卡松气雾剂联合噻托溴铵对重度-极重度COPD患者肺功能和生活质量的改善作用[J].中国老年学杂志,2010,30(15):2212-2213. 被引量：14
3杨勇刚,胡强,王利玲,陈余思.鲑鱼降钙素治疗慢性阻塞性肺疾病合并骨质疏松症的疗效观察[J].中国医药指南,2010,8(29):224-226. 被引量：1
4田燕歌.“治未病”理论在慢性阻塞性肺疾病防治中的应用[J].辽宁中医杂志,2011,38(4):640-641. 被引量：3
5黄燕,韩文铭,倪娜.COPD患者骨密度与肿瘤坏死因子-α的关系[J].临床肺科杂志,2011,16(7):1034-1036. 被引量：4
6刘嘉眉.老年慢性阻塞性肺疾病合并骨质疏松症的临床分析[J].中国医药指南,2012,10(10):52-54. 被引量：6
7左莹,雷震.老年男性COPD患者骨密度及骨代谢相关指标的观察[J].西南国防医药,2012,22(6):621-623. 被引量：1
8赵星辰,田京.低氧与成骨及破骨细胞代谢[J].中国组织工程研究,2012,16(28):5277-5280. 被引量：6
9吴泽龙.COPD并发骨质疏松相关危险因素研究[J].临床肺科杂志,2012,17(10):1880-1881. 被引量：11
10林腊梅,丁念,戴燚,魏圣青,赵雅靓,黄金元.慢性阻塞性肺病继发骨质疏松症的相关因素探讨[J].湖北中医杂志,2013,35(3):29-31. 被引量：1

同被引文献33

1Felitti VJ, Anda RF, Nordenberg D, et al. The relationship of adverse childhood experiences to many of the leading cause of death in the Unit-ed States: The Adverse Childhood Experieuoes Study[J]. Am J Prey M ed,2008,14:245 - 258.
2杨菊,张燕祺,马蕾,等.老年慢性阻塞性肺疾病与骨质疏松症的相关性研究[J].2009,7(4):31-33.
3Knowles HI, Athanasou NA. Hypoxia - inducible factor is expressed in giant cell tumour of bone and mediates pamcrine effects of hypoxla on monecyte- ostecclast differentiation via induction of VEGF [ J ]. J Pathol. 2008 ;215 ( 1 ) :56 - 66.
4Utting JC, Flanagan AM, Brandao - Butch A, et al. Hypoxia stimulates osteoclast formation from human peripheral blood [J]. Cell Biochem Funct ,2010 ,28 (5) :374 - 380.
5吴泽龙.COPD并发骨质疏松相关危险因素研究[J].临床肺病杂志,2012,17(10):1880-1181.
6Gao SG, Cheng L, Li KH,, et al. Effect o epimedium pubescen fla- vonoid on bone mineral status and bone turnover in male rats chronical- ly exposed to cigarette smoke[J]. BMC Musculoskelet Disorcl, 2012, 13:105.
7黄志俭,罗琴,凌敏,等.慢性阻塞性肺病体重指数与肺功能的相关性研究[J].临床肺病杂志,2009,14(1):14-15.
8Vrieze A, de Greef MH, Wykstra PJ. Low bone mineral density in COPD patients related to worse lung function, low weight and de- creased Fat -free mass[J]. Osteoporos Int, 2007, 18(9) : 1197 - 1202.
9Kjensli A,Mowinckel P,Ryg MS,et al. Low bone mineral density is re- lated to severity of chronic obstructive pulmonary disease [ J ]. Bone, 2007 ;40(2 ) :493 -497.
10Leidig-Bruckner G, Roth H J, Bruckner T, et al. Are commonly recommended dosages for vitamin D status and effects of supplementation on serum 25-hydrox-yvitamin D levelsan observational study during clinical practice conditions [J]. Osteoporos Int ,2010,17:16 - 25.